No Data
Zhejiang Zhenyuan: Report for the first quarter of 2025
Zhejiang Zhenyuan: 2024 Annual Report
Zhejiang Zhenyuan: 2024 Annual Report Summary
Zhejiang Zhenyuan Share (000705.SZ): The net income for the first quarter is 35.8826 million yuan, a year-on-year increase of 86.44%.
On April 28, Glonghui reported that Zhejiang Zhenyuan Share (000705.SZ) released its Q1 2025 report, achieving revenue of 0.752 billion yuan during the reporting period, a decrease of 28.05% year-on-year; Net income attributable to shareholders of the listed company was 35.8826 million yuan, an increase of 86.44% year-on-year; Net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 12.3712 million yuan, a decrease of 33.25% year-on-year; EPS was 0.1074 yuan.
Two Sessions Time | National People's Congress Representative, Lu Qingguo from Chenguang Biotech Group: Improve the quality standards of Chinese Patent Medicine, regulate the centralized procurement model for Traditional Chinese Medicine, and optimize the
① Lu Qingguo, Director of Chenguang Biotech Group and a representative of the National People's Congress, focused on several recommendations at this year's Two Sessions, including optimizing the procurement mechanism for Traditional Chinese Medicine, enhancing the quality standards for Chinese Patent Medicine, and standardizing the Traditional Chinese Medicine granule industry; ② In addition to recommendations related to the Traditional Chinese Medicine industry, Lu Qingguo prepared several suggestions on rural social retirement insurance, rural medical insurance, and increasing support for companies sanctioned by the United States.
Zhejiang Zhenyuan Share (000705.SZ): The equity structure of the controlling Shareholder has changed.
Gelonghui reported on February 10th that Zhejiang Zhenyuan Share (000705.SZ) announced that it recently received a notification from its controlling shareholder, Shaoxing Zhenyuan Health Industry Group Co., Ltd. (referred to as "Zhenyuan Health Group"), informing that the equity structure of Zhenyuan Health Group has changed, and it has obtained the "Business License" issued by the Shaoxing Municipal Market Supervision Administration. According to the "Implementation Plan for the Deepening and Enhancement Action of State-owned Enterprise Reform in Shaoxing City (2024-2025)" and the relevant requirements of the "Restructuring and Optimization Plan for State-owned Enterprises in Shaoxing City," Shaoxing State-owned Capital Operation Co., Ltd. (referred to as "Shaoxing State-owned Operation") will Hold Zhenyuan.
Are Zhejiang Zhenyuan Share Co.,Ltd.'s (SZSE:000705) Mixed Financials Driving The Negative Sentiment?
